World News | Ariana Eunjung Cha, The Washington Post | Tuesday September 22, 2015
John Carroll, the editor of Fierce Biotech, a daily newsletter about the industry, was one of the first to ask Turing chief executive Martin Shkreli directly to explain the move.
www.ndtv.com